Xponance, Inc. Merck & Co., Inc. Transaction History

Xponance, Inc.

$10.2 Billion
Q3 2024

A detailed history of Xponance, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Xponance, Inc. holds 585,139 shares of MRK stock, worth $58.2 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares

585,139

Previous 591,394 1.06%

Holding current value

$58.2 Million

Previous $73.2 Million 9.24%

% of portfolio

0.65%

Previous 0.76%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$111.15 - $128.97 $695,243 - $806,707	-6,255 Reduced 1.06%	585,139 $66.4 Million
Q2 2024 Aug 14, 2024	BUY	$123.8 - $132.96 $23.4 Million - $25.2 Million	189,196 Added 47.04%	591,394 $73.2 Million
Q1 2024 May 13, 2024	SELL	$113.24 - $131.95 $1.17 Million - $1.37 Million	-10,358 Reduced 2.51%	402,198 $53.1 Million
Q4 2023 Jan 31, 2024	BUY	$100.18 - $109.02 $2.85 Million - $3.1 Million	28,406 Added 7.39%	412,556 $45 Million
Q3 2023 Oct 23, 2023	BUY	$102.95 - $114.33 $613,787 - $681,635	5,962 Added 1.58%	384,150 $39.5 Million
Q2 2023 Jul 13, 2023	SELL	$108.61 - $118.38 $6.36 Million - $6.94 Million	-58,598 Reduced 13.42%	378,188 $43.6 Million
Q1 2023 Apr 17, 2023	BUY	$102.94 - $114.86 $1.34 Million - $1.49 Million	12,970 Added 3.06%	436,786 $46.5 Million
Q4 2022 Jan 23, 2023	BUY	$87.44 - $112.11 $3.62 Million - $4.64 Million	41,361 Added 10.81%	423,816 $0
Q3 2022 Oct 24, 2022	BUY	$84.53 - $94.96 $3.49 Million - $3.92 Million	41,273 Added 12.1%	382,455 $32.9 Million
Q2 2022 Aug 02, 2022	BUY	$83.49 - $94.64 $11.5 Million - $13 Million	137,166 Added 67.23%	341,182 $31.1 Million
Q1 2022 Apr 20, 2022	BUY	$73.51 - $82.4 $345,938 - $387,774	4,706 Added 2.36%	204,016 $16.7 Million
Q4 2021 Jan 31, 2022	BUY	$72.28 - $90.54 $4.93 Million - $6.18 Million	68,210 Added 52.03%	199,310 $15.3 Million
Q3 2021 Nov 05, 2021	SELL	$71.68 - $78.83 $1.68 Million - $1.85 Million	-23,410 Reduced 15.15%	131,100 $9.85 Million
Q2 2021 Aug 12, 2021	SELL	$70.31 - $77.77 $21.4 Million - $23.7 Million	-304,792 Reduced 66.36%	154,510 $12 Million
Q1 2021 May 10, 2021	SELL	$68.86 - $81.11 $118,990 - $140,158	-1,728 Reduced 0.37%	459,302 $35.4 Million
Q4 2020 Feb 11, 2021	BUY	$71.77 - $79.65 $204,831 - $227,321	2,854 Added 0.62%	461,030 $37.7 Million
Q3 2020 Oct 26, 2020	SELL	$73.18 - $82.95 $1.98 Million - $2.24 Million	-27,007 Reduced 5.57%	458,176 $38 Million
Q2 2020 Aug 14, 2020	BUY	$70.42 - $80.13 $34.2 Million - $38.9 Million	485,183 New	485,183 $37.5 Million

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $252B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.

Account